Cipla launches RT-PCR test kit ViraGen in India partnership with Ubio Biotech PTI
Updated : May 20, 2021, 12:42 pm IST
The company will commence supply of the COVID-19 virus detection kit from May 25, 2021
ViraGen is Cipla s third offering in the COVID-19 testing segment. (Photo: PTI)
New Delhi: Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit ViraGen for COVID-19 in India, in partnership with Ubio Biotechnology Systems. This launch will help address the current testing services and capacity issues while reaffirming the company s ongoing expansion in the diagnostic space, Cipla said in a regulatory filing.
Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.